Chordoma Clinical Trials
48 clinical trials for Chordoma across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Children and Adults With Chordoma — RECRUITING
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — RECRUITING · PHASE1
- Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone — RECRUITING
- Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base — RECRUITING · NA
- Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease — RECRUITING · NA
- Pembrolizumab and Pemetrexed for Progressive Chordoma — RECRUITING · PHASE2
- Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy — RECRUITING · NA
- Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas — RECRUITING
- Clinical Genetics Branch Eligibility Screening Survey — NOT_YET_RECRUITING
- Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers — ACTIVE_NOT_RECRUITING · PHASE2
- Nivolumab and Ipilimumab in Treating Patients With Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
- Proton Beam Therapy for Chordoma Patients — ACTIVE_NOT_RECRUITING · PHASE2
- Long-Term Longitudinal QoL in Patients Undergoing EEA — ACTIVE_NOT_RECRUITING
- A Study of ERAS-601 in People With Chordoma — ACTIVE_NOT_RECRUITING · PHASE1
- Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors — ACTIVE_NOT_RECRUITING · PHASE1
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma — ACTIVE_NOT_RECRUITING · PHASE2
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast — OTHER
- Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma — ACTIVE_NOT_RECRUITING · PHASE2
- Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma — ACTIVE_NOT_RECRUITING · PHASE1
- Nilotinib With Radiation for High Risk Chordoma — COMPLETED · PHASE1
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE — COMPLETED
- TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer — COMPLETED · PHASE1
- QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. — WITHDRAWN · PHASE1
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers — COMPLETED · PHASE1
- Afatinib in Locally Advanced and Metastatic Chordoma — COMPLETED · PHASE2
- QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma — COMPLETED · PHASE2
- Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma — COMPLETED · PHASE2
- Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. — OTHER · PHASE2
- Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma — OTHER · PHASE2
- Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma — COMPLETED
- BN Brachyury and Radiation in Chordoma — COMPLETED · PHASE2
- CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma — COMPLETED · PHASE2
- Pemetrexed for the Treatment of Chordoma — COMPLETED · PHASE1
- A Study of IMRT in Primary Bone and Soft Tissue Sarcoma — COMPLETED · NA
- Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care — COMPLETED
- Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families — COMPLETED
- Stereotactic Body Radiotherapy for Spine Tumors — COMPLETED · NA
- Chordoma Family Study — COMPLETED
- Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma — OTHER · PHASE2
- Trial of Dasatinib in Advanced Sarcomas — COMPLETED · PHASE2
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors — TERMINATED · PHASE1
- Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine — COMPLETED · PHASE1
- Efficacy and Safety of Imatinib in Chordoma — COMPLETED · PHASE2
- Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas — COMPLETED · NA
- Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas — COMPLETED
- Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer — OTHER · NA
- Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma — OTHER · PHASE1
- Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base — OTHER · PHASE3
Refine this search